Arthur T. Skarin - Concepedia

Author

Arthur T. Skarin

Also Known As

A Skarin, A T Skarin, A. Skarin, A. T. Skarin, A.T Skarin, A.T. Skarin, ARTHUR T. SKARIN, Arthur Skarin, Arthur T Skarin, Arthur T. Skarin

154

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Dana-Farber Brigham Cancer Center Massachusetts General Hospital

About

Arthur T. Skarin is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	53	3.5K
2	Health Sciences	17	19	1.9K
3	Public Health	2	2	169
4	Engineering	1	1	12
5	Language Studies	1	1	198

Arthur T. Skarin

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung Michael C. Perry, Walter L. Eaton, Kathleen J. Propert, New England Journal of Medicine Initial RadiotherapyRadiation MedicineRadiation TherapyMedicineToxic Effects	1987	489
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). Arthur T. Skarin, G P Canellos, David S. H. Rosenthal, Journal of Clinical Oncology Hematological MalignancyNeuro-oncologyAdvanced DiffuseUndifferentiated LymphomaLymphoid Neoplasia	1983	340
Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer David M. Jackman, Beow Y. Yeap, Neal I. Lindeman, Journal of Clinical Oncology	2007	306
Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma Ravi Salgia, Thomas J. Lynch, Arthur T. Skarin, Journal of Clinical Oncology	2003	294
Multimodality therapy for malignant mesothelioma based on a study of natural history Karen H. Antman, Ronald H. Blum, Joel S. Greenberger, The American Journal of Medicine Malignant MesotheliomaMultimodality TherapyNatural HistoryMultimodalityOncology	1980	212
Microangiopathic Hemolytic Anemia and Cancer Karen H. Antman, Arthur T. Skarin, Robert J. Mayer, Medicine Author InformationComparative LiteratureContemporary FictionMalignant Blood DisorderHematology	1979	198
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study Pasi A. Jänne, Sarada Gurubhagavatula, Beow Y. Yeap, Lung Cancer MedicineExpanded Access StudyCancer ManagementClinical Trials‘ Iressa ’	2004	197
High Risk of Brain Metastases in Surgically Staged IIIA Non–Small-Cell Lung Cancer Patients Treated With Surgery, Chemotherapy, and Radiation Harvey J. Mamon, Beow Y. Yeap, Pasi A. Jänne, Journal of Clinical Oncology	2005	197
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. A. Philippe Chahinian, Kathleen J. Propert, John Ware, Journal of Clinical Oncology Cancer ManagementPharmacotherapyMetronomic ChemotherapyHematological MalignancyThrombosis	1989	193
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Arthur T. Skarin, David S. H. Rosenthal, William C. Moloney, PubMed	1977	161

Page 1